Mar 10,2022

Digital mental health company HelloBetter raises Series A extension led by MassMutual Ventures

HelloBetter, a Berlin-based, digital mental healthcare company, announces a €4 million extension of its recently announced €6 million Series A funding round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 29,2022

Healthtech Platform: BeatO raises Rs 27 Cr in debt via existing members

BeatO, the Delhi-NCR based healthtech platform, has raised convertible debt of Rs 27 crore from their existing investors. At issue price of Rs 1350 per debentures, the company has passed a special resolution to allot 1,99,538 Series A CCD in order to raise 27 crore or $3.6 million. With 11.25 crore, the debt round is led by W Health Global LLC, followed by Sage Hill Investors and Kotak Investments with 3.75 crore and Rs 5 crore respectively.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
May 07,2022

Biolinq Receives $62 Million from Investors

Biolinq Inc. received $62 million fudning from the investors according to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 23,2022

Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, announces today that it has secured $5 million in non-dilutive funding though a clean debt facility with no warrants or convertible elements.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Jul 13,2022

NutriSense Raises $25 Million to Drive Continued Growth

NutriSense, the metabolic health technology platform that couples real-time data with credentialed nutrition professionals for personalized support, announced the initial closing of a $25 million Series A round. This financing, led by 1315 Capital, a healthcare growth equity firm, will be used to drive continued growth as the company serves more consumers seeking to optimize their nutritional wellness and metabolic health.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 03,2022

Stability Health Secures $7 Million

Stability Health received $7.2 million funding from the investors according to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 15,2022

JanuaryAI Secures $13 Million in Debt Financing

According to the SEC form, JanuaryAI received $13 million in the debt financing.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Aug 25,2022

Brighter’s Board of Directors secures financing for further commercialization through a rights issue of units of approximately SEK 52.4 million and procures loan financing

The Board of Directors of Brighter AB has today, with authorization from the general meeting in the Company on June 8, 2022, decided to carry out of an issue of units consisting of shares and warrants with preferential rights for existing shareholders of approximately SEK 52.4 million

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Sep 10,2022

HEALTHTECH START-UP BEATO RAISES RS 18 CRORE FROM ALTERIA

DELHI-BASED DIABETES MONITORING platform BeatO has raised Rs 18 crore from Alteria Capital as debt in the Series B funding round. With this, the company has received financing for the second time this year. The company raised debt worth Rs 27 crore in April this year led by existing backers W Health Global LLC, Kotak Investments, and Sage Hill Investors.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Sep 15,2022

Medtronic announces closing of public offering of €3.5 billion of senior notes

Medtronic plc today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. has closed a registered public offering of €500,000,000 principal amount of 2.625% Senior Notes due 2025, €1,000,000,000 principal amount of 3.000% Senior Notes due 2028, €1,000,000,000 principal amount of 3.125% Senior Notes due 2031 and €1,000,000,000 principal amount of 3.375% Senior Notes due 2034. The net proceeds from the Offering are approximately €3.47 billion, after deducting underwriting discounts and commissions and estimated expenses related to the Offering payable by Medtronic Luxco.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING